Audio-Based Mental Health Intervention for Depression
Trial Summary
What is the purpose of this trial?
This is a study on an audio-based digital intervention designed to reduce symptoms of depression. Participants who experience at least moderate symptoms of depression will be invited to participate in the study. Participants will be randomly assigned to receive one of two audio-based digital interventions. The experimental intervention based on behavioral activation treatment for depression. The control intervention is based on self-monitoring. Depression symptoms and related mental health symptoms, as well as experiences with the intervention, will be assessed at baseline (pre-randomization), mid-intervention (1 week post-randomization), post-intervention (2 weeks post-randomization) and follow-up (5 weeks post-randomization)
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the audio-based mental health treatment for depression?
Is audio-based mental health intervention for depression safe for humans?
How is the audio-based behavioral activation intervention for depression different from other treatments?
This treatment is unique because it uses audio-based guidance to deliver behavioral activation, making it more accessible and convenient for people who may not have access to traditional therapy sessions. Unlike standard treatments that require in-person interaction, this approach can be delivered digitally, potentially reaching a wider audience and providing support in a more flexible manner.12368
Research Team
Eligibility Criteria
This trial is for adults over 18 who can read, write, and speak English well. They must have moderate or severe depression confirmed by an interview and a specific depression screening test. Participants need to be able to consent to the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of two audio-based digital interventions over two weeks, with sessions delivered one week apart
Follow-up
Participants are monitored for changes in symptoms of depression, anxiety, stress, and affect, as well as intervention satisfaction
Treatment Details
Interventions
- Audio-based behavioral activation intervention (Behavioural Intervention)
- Audio-based self-monitoring intervention (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor
Lindsay A. Rosenwald
Penn State University
Chief Medical Officer since 2013
MD from Temple University School of Medicine
Scott Tarriff
Penn State University
Chief Executive Officer since 2007
B.S. in Marketing from Pennsylvania State University, MBA from Rider College